Cargando…
A New Regioselective Synthesis of the Cysteine-Rich Peptide Linaclotide
Linaclotide is a 14-amino acid residue peptide approved by the FDA for the treatment of irritable bowel syndrome with constipation (IBS-C), which activates guanylate cyclase C to accelerate intestinal transit. Here we show a new method for the synthesis of linaclotide through the completely selectiv...
Autores principales: | Qiu, Zhonghao, Dai, Xiandong, Fan, Chongxu, Cao, Ying, Lv, Zirui, Liang, Xingyong, Meng, Fanhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919235/ https://www.ncbi.nlm.nih.gov/pubmed/36770675 http://dx.doi.org/10.3390/molecules28031007 |
Ejemplares similares
-
Engineering of an Anti-Inflammatory Peptide Based on the Disulfide-Rich Linaclotide Scaffold
por: Cobos, Claudia, et al.
Publicado: (2018) -
Improving the Gastrointestinal
Stability of Linaclotide
por: Braga Emidio, Nayara, et al.
Publicado: (2021) -
Synthesis, Screening, and Sequencing of Cysteine-Rich One-Bead One-Compound Peptide Libraries
por: Juskowiak, Gary L., et al.
Publicado: (2008) -
Review article: linaclotide for the management of irritable bowel syndrome with constipation
por: Layer, P, et al.
Publicado: (2014) -
Linaclotide for the treatment of refractory lower bowel manifestations of systemic sclerosis
por: Dein, Eric J., et al.
Publicado: (2021)